4//SEC Filing
Kassberg Thomas Richard 4
Accession 0000950170-24-029780
CIK 0001515673other
Filed
Mar 11, 8:00 PM ET
Accepted
Mar 12, 1:41 PM ET
Size
5.1 KB
Accession
0000950170-24-029780
Insider Transaction Report
Form 4
Kassberg Thomas Richard
CBO & Senior Vice President
Transactions
- Sale
Common Stock
2024-03-11$49.93/sh−11,509$574,644→ 252,823 total
Footnotes (2)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $49.92 to $50.06 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
- [F2]Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions.
Documents
Issuer
Ultragenyx Pharmaceutical Inc.
CIK 0001515673
Entity typeother
Related Parties
1- filerCIK 0001303811
Filing Metadata
- Form type
- 4
- Filed
- Mar 11, 8:00 PM ET
- Accepted
- Mar 12, 1:41 PM ET
- Size
- 5.1 KB